Converge Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 5.00 M
as on 16-11-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.58 Cr
as on 16-11-2024
- Satisfied Charges ₹ 2.55 Cr
as on 16-11-2024
- Revenue 7.51%
(FY 2023)
- Profit -143.22%
(FY 2023)
- Ebitda -77.28%
(FY 2023)
- Net Worth -18.00%
(FY 2023)
- Total Assets 24.47%
(FY 2023)
About Converge Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹8.58 Cr. The company has closed loans amounting to ₹2.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chandra Bukka, Bukka Srinivasu, Bijjala Kavitha, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233TG2014PTC095410
- Company No.
095410
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Aug 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Converge Biotech Private Limited offer?
Converge Biotech Private Limited offers a wide range of products and services, including Nutritional Supplements, Multivitamin Supplements, Antidepressant & Anti Anxiety Medicines, Pregabalin Capsules, Antibacterial Drugs, Cefoperazone Sulbactam Injection, Vitamin Tablets & Capsules, Vitamin D3 Tablets & Capsules, Anticoagulant and Antiplatelet Drugs, Enoxaparin Injection.
Who are the key members and board of directors at Converge Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bijjala Kumar  | Managing Director | 26-Aug-2014 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandra Bukka | Director | 26-Aug-2014 | Current |
| Bukka Srinivasu | Director | 26-Aug-2014 | Current |
| Bijjala Kavitha | Director | 26-Aug-2014 | Current |
Financial Performance of Converge Biotech.
Converge Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.51% increase. The company also saw a substantial fall in profitability, with a 143.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Converge Biotech?
In 2023, Converge Biotech had a promoter holding of 74.91% and a public holding of 25.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Santhoshimathaa Edible Oils Refinery Private LimitedActive 12 years 10 monthsChandra Bukka and Bukka Srinivasu are mutual person
- Santhoshimathaa Oils And Fats Private LimitedActive 9 years 7 months
Chandra Bukka and Bukka Srinivasu are mutual person
Santhoshimatha Bio Fuels Private LimitedActive 5 years 1 monthChandra Bukka and Bukka Srinivasu are mutual person
- Santhoshimatha Agro Refinery India Private LimitedActive 3 years 2 months
Chandra Bukka and Bukka Srinivasu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Feb 2024 | ₹2.41 M | Open |
Hdfc Bank Limited Creation Date: 27 Oct 2021 | ₹8.34 Cr | Open |
Karnataka Bank Ltd. Creation Date: 06 Jul 2020 | ₹3.50 M | Satisfied |
How Many Employees Work at Converge Biotech?
Converge Biotech has a workforce of 171 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Converge Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Converge Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
